Ovation Science Inc.
OVAT
CNSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -47.75% | -23.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -47.75% | -23.45% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -47.75% | 2,120.00% | |||
| SG&A Expenses | 51.78% | -52.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 51.78% | -55.93% | |||
| Operating Income | -67.66% | 58.73% | |||
| Income Before Tax | -60.57% | 55.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -60.57% | 55.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -60.57% | 55.59% | |||
| EBIT | -67.66% | 58.73% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -60.00% | 57.45% | |||
| Normalized Basic EPS | -66.67% | 58.62% | |||
| EPS Diluted | -60.00% | 57.45% | |||
| Normalized Diluted EPS | -66.67% | 58.62% | |||
| Average Basic Shares Outstanding | 0.00% | 4.80% | |||
| Average Diluted Shares Outstanding | 0.00% | 4.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||